Editorial comment on Prostate-specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate
- PMID: 37919878
- DOI: 10.1111/iju.15334
Editorial comment on Prostate-specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate
References
REFERENCES
-
- Kimura S, Katayama H, Ohara E, Aoki H, Shibuya R, Naganuma H, et al. Prostate specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate. Int J Urol. 2023. doi: 10.1111/iju.15315.
-
- Lambert E, Goossens M, Palagonia E, Vollemaere J, Mazzone E, Dell'Oglio P, et al. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer. World J Urol. 2021;39:2621-2626.
-
- Klein C, Marquette T, Capon G, Yacoub M, Alezra E, Bernhard JC, et al. Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression. Int J Clin Oncol. 2022;27:1077-1083.
-
- Tominaga Y, Sadahira T, Mitsui Y, Maruyama Y, Tanimoto R, Wada K, et al. Favorable long-term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate. Mol Clin Oncol. 2019;10:605-609.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
